Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 6/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL1662199 | 1.00 | FABP3 (0.45) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Dodecanoate SCHEMBL1661287 | 1.00 | FABP3 (0.45) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Heptanoate SCHEMBL1661522 | 1.00 | FABP3 (0.45) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Stearic Acid SCHEMBL22362218 | 1.00 | FABP3 (0.45) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Nonanoate SCHEMBL1661376 | 1.00 | FABP3 (0.45) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Undecanoate SCHEMBL1663984 | 1.00 | FABP3 (0.45) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783479 | 0.90 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783469 | 0.90 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783450 | 0.90 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Myristic Acid SCHEMBL28783468 | 0.90 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190024263-A1 | LYOCELL FIBER AND MANUFACTURING METHOD THEREFOR | KOLON INDUSTRIES, INC. (KR) | 2019-01-24 | — | — | US | claimed |
| EP-2486175-B1 | A PROCESS OF MANUFACTURING LOW FIBRILLATING CELLULOSE FIBERS | GRASIM IND LTD (IN) | 2015-05-20 | — | — | EP | claimed |
| US-8952146-B2 | Process for manufacturing low-fibrillating cellulosic fiber | GRASIM INDUSTRIES LIMITED (IN) | 2015-02-10 | — | — | US | claimed |
| WO-2014207100-A1 | A PROCESS FOR COATING PAPER WITH CELLULOSE USING A SOLUTION CONTAINING CELLULOSE | BASF SE (DE) | 2014-12-31 | — | — | WO | claimed |
| US-8841441-B2 | Method for producing regenerated biopolymers and regenerated products obtained by said method | BASF SE (DE) | 2014-09-23 | — | — | US | claimed |
| EP-1966284-B1 | SOLVENT SYSTEM BASED ON MOLTEN IONIC LIQUIDS, ITS PRODUCTION AND USE FOR PRODUCING REGENERATED CARBOHYDRATES | BASF SE (DE) | 2013-04-17 | — | — | EP | claimed |
| US-20120253030-A1 | PROCESS FOR MANUFACTURING LOW-FIBRILLATING CELLULOSIC FIBER | GRASIM INDUSTRIES LIMITED (IN) | 2012-10-04 | — | — | US | claimed |
| US-20120253031-A1 | PROCESS FOR MANUFACTURING LOW-FIBRILLATING CELLULOSIC FIBER | GRASIM INDUSTRIES LIMITED (IN) | 2012-10-04 | — | — | US | claimed |
| EP-2486062-A2 | A PROCESS OF MANUFACTURING LOW-FIBRILLATING CELLULOSIC FIBERS | Grasim Industries Limited (IN) | 2012-08-15 | — | — | EP | claimed |
| US-8163215-B2 | Contains 1-ethyl-3-methylimidazolium acetate; precipitation; spun fibers | BASF AKTIENGESELLSCHAFT (DE) | 2012-04-24 | — | — | US | claimed |
| WO-2011048608-A2 | A PROCESS OF MANUFACTURING LOW-FIBRILLATING CELLULOSIC FIBERS | GRASIM INDUSTRIES LIMITED (IN) | 2011-04-28 | — | — | WO | claimed |
| US-20100256352-A1 | METHOD FOR PRODUCING REGENERATED BIOPOLYMERS AND REGENERATED PRODUCTS OBTAINED BY SAID METHOD | BASF SE (DE) | 2010-10-07 | — | — | US | claimed |
| US-20080269477-A1 | Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates | BASF SE (DE) | 2008-10-30 | — | — | US | claimed |
| EP-4093998-B1 | VALVE | AUROTEC GMBH (AT) | 2025-09-03 | — | — | EP | disclosed |
| EP-3901333-B1 | PRODUCTION OF FILAMENTS WITH CONTROLLED GAS FLOW | AUROTEC GMBH (AT) | 2025-08-13 | — | — | EP | disclosed |
| US-12247321-B2 | Process for the preparation of polymer fibers from polymers dissolved in ionic liquids by means of an air gap spinning process | TECHNIKUM LAUBHOLZ GMBH (DE) | 2025-03-11 | — | — | US | disclosed |
| WO-2011048608-A2 | A PROCESS OF MANUFACTURING LOW-FIBRILLATING CELLULOSIC FIBERS | GRASIM INDUSTRIES LIMITED (IN) | 2011-04-28 | — | — | WO | disclosed |
| US-20100256352-A1 | METHOD FOR PRODUCING REGENERATED BIOPOLYMERS AND REGENERATED PRODUCTS OBTAINED BY SAID METHOD | BASF SE (DE) | 2010-10-07 | — | — | US | disclosed |
| US-20100081798-A1 | METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION | BASF SE (DE) | 2010-04-01 | — | — | US | disclosed |
| US-20080269477-A1 | Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081798-A1 | METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION | MGAM, LCT, SI | FABP3 2942/4885MEN1 2926/4885HSP90AA1 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.